Sanofi-Aventis (ADR) (SNY)
$36.70
-0.35 (-0.94%)
| CAPS Rating |
|
|---|---|
| Open | $36.23 |
| Previous Close | $37.05 |
| Daily Range | $36.17 - $36.73 |
| 52-Week Range | $23.95 - $40.17 |
| Market Cap | $96.56B |
| P/E Ratio | 19.92 |
| Dividend (Yield) | 1.12 (3.00%) |
| Volume | 1,286,548 |
| Average Daily Volume | 1,651,000 |
SNY
VS S&P 500 (SPY)
How do you think SNY will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
SNY Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
SNY News and Commentary
- CNBC on Sanofi-Aventis ADS – Ockham-RazorWire
- CNBC on Sanofi-Aventis ADS – Ockham-RazorWire
- The Downside of Dollar-Cost Averaging – The Motley Fool
- Slow Down There, Merck – The Motley Fool
- An Ode to Schering-Plough – The Motley Fool
- This Stable Stock Could Still Surprise – The Motley Fool
- Shrugging Off the Side Effects – The Motley Fool
- Of One-Time Gains and Pipelines – The Motley Fool
- Eye on Insiders: Amgen – The Motley Fool
- The Winning Opportunity No One Talks About – The Motley Fool
- 4-Star Stocks Poised to Pop: Elan – The Motley Fool
- I Don't Need No Massive Merger – The Motley Fool
- Merck-Schering Doesn't Look So Good – The Motley Fool
- Still Waiting for Its Blockbuster – The Motley Fool
- The HPV Vaccine Wars of 2010 – The Motley Fool
- 5 Stocks Springing Back – The Motley Fool
- J&J Needs to Get Drugged Up – The Motley Fool
- 5-Star Stocks Poised to Pop: Novo Nordisk – The Motley Fool
- Dendreon soon to be part of a major pharma – Blog at The Motley Fool
- Why I'm Invested in Tysabri and Elan – The Motley Fool
RSS Headlines
Fool UK
